Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants
Clinical trial NCT06169085 · COMPLETED
Trial details
- NCT number
- NCT06169085
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2023-09-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.